Jefferies Examines The Effect Of Sarepta’s Drug Approval On PTC Therapeutics

PTC Therapeutics, Inc. PTCT 4.79% shares are up another 4.2 percent in early Tuesday trading following a big 20.6 percent Monday gain. The big move in PTC shares has been driven by the FDA’s accelerated approval of Sarepta Therapeutics Inc SRPT 8.45%’s Eteplirsen for treatment of exon 51 skipping amenable Duchenne’s muscular dystrophy.

The market seems to take the FDA approval of Eteplirsen as a positive sign for PTC’s own Duchenne’s muscular dystrophy drug, Ataluren. However, Jefferies analyst Gena Wang is not convinced. According to Wang, the FDA approval of Eteplirsen was based on a key piece of data that Ataluren’s Phase III trial is lacking.

Key Difference Between PTC And Sarepta’s Muscular Dystrophy Rx

“Although PTCT’s ataluren is considered safe, the FDA approval of eteplirsen is mainly based on the marginal increase of dystrophin level while PTCT does not have any dystrophin data from PH3,” Wang explained.

Back in Q2, PTC submitted an appeal of the FDA’s Refuse to File letter regarding Ataluren. While Wang believes that approval of Eteplirsen could pressure the FDA to review the appeal in the near future, she doesn’t believe…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common SenseI don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!